Neurology and Neurosurgery - Global Neurology Academy

257-272 of 546

Managing MS in Older Adults: Key Considerations for DMTs and Lifestyle Interventions
Managing MS in Older Adults: Key Considerations for DMTs and Lifestyle Interventions
On the Frontlines of Multiple Sclerosis
Managing MS in Older Adults: Key Considerations for DMTs and Lifestyle Interventions
Charles Turck, PharmD, BCPS, BCCCP; Kimberly DiMauro, DO
- Charles Turck, PharmD, BCPS, BCCCP
- Kimberly DiMauro, DO
- Carol Swetlik, MD
Mapping Brain Atrophy in Schizophrenia
Mapping Brain Atrophy in Schizophrenia
On the Frontlines of Schizophrenia
Mapping Brain Atrophy in Schizophrenia
Ahmed Makhlouf, MD
- Ahmed Makhlouf, MD
MS Management: Strategies for Ensuring Equitable Access to Teleneurology
MS Management: Strategies for Ensuring Equitable Access to Teleneurology
On the Frontlines of Multiple Sclerosis
MS Management: Strategies for Ensuring Equitable Access to Teleneurology
Marisa McGinley, DO
- Marisa McGinley, DO
Understanding Schizophrenia: Early Intervention and Prevention Strategies
Understanding Schizophrenia: Early Intervention and Prevention Strategies
On the Frontlines of Schizophrenia
Understanding Schizophrenia: Early Intervention and Prevention Strategies
Joseph F. Goldberg, MD
- Joseph F. Goldberg, MD
Optimizing Schizophrenia Care: Strategies for Managing Side Effects and Treatment Resistance
Optimizing Schizophrenia Care: Strategies for Managing Side Effects and Treatment Resistance
On the Frontlines of Schizophrenia
Optimizing Schizophrenia Care: Strategies for Managing Side Effects and Treatment Resistance
Joseph F. Goldberg, MD
- Joseph F. Goldberg, MD
Reducing Cortical Lesions in MS with Ocrelizumab: Results from the ORATORI Study
Reducing Cortical Lesions in MS with Ocrelizumab: Results from the ORATORI Study
NeuroFrontiers
Reducing Cortical Lesions in MS with Ocrelizumab: Results from the ORATORI Study
Michael G. Dwyer, PhD
- Michael G. Dwyer, PhD
Studying Cortical Lesions in MS: Future Research Directions
Studying Cortical Lesions in MS: Future Research Directions
NeuroFrontiers
Studying Cortical Lesions in MS: Future Research Directions
Michael G. Dwyer, PhD
- Michael G. Dwyer, PhD
Unraveling the Mechanism: How Ocrelizumab Impacts Cortical Lesions in MS
Unraveling the Mechanism: How Ocrelizumab Impacts Cortical Lesions in MS
NeuroFrontiers
Unraveling the Mechanism: How Ocrelizumab Impacts Cortical Lesions in MS
Michael G. Dwyer, PhD
- Michael G. Dwyer, PhD
From Diagnosis to Treatment: Challenges in Glioblastoma Care
From Diagnosis to Treatment: Challenges in Glioblastoma Care
NeuroFrontiers
From Diagnosis to Treatment: Challenges in Glioblastoma Care
Lauren Schaff, MD
- Lauren Schaff, MD
Climate Change in the Clinic: Examining Neurological Impacts
Climate Change in the Clinic: Examining Neurological Impacts
NeuroFrontiers
Climate Change in the Clinic: Examining Neurological Impacts
Beth Ann Malow, MD, MS
- Beth Ann Malow, MD, MS
Vorasidenib and mIDH Gliomas: Reviewing the Efficacy Data
Vorasidenib and mIDH Gliomas: Reviewing the Efficacy Data
NeuroFrontiers
Vorasidenib and mIDH Gliomas: Reviewing the Efficacy Data
Jennie Taylor, MD
- Jennie Taylor, MD
mIDH Gliomas Explained: Characteristics and Management Strategies
mIDH Gliomas Explained: Characteristics and Management Strategies
NeuroFrontiers
mIDH Gliomas Explained: Characteristics and Management Strategies
Jennie Taylor, MD
- Jennie Taylor, MD
Decoding CIDP: Pathogenesis, Diagnosis, and Clinical Clues
Decoding CIDP: Pathogenesis, Diagnosis, and Clinical Clues
Global Neurology Academy
Decoding CIDP: Pathogenesis, Diagnosis, and Clinical Clues
Hans Katzberg, MD
- Hans Katzberg, MD
Evolving Strategies in CIDP Care: Personalized Approaches and Emerging Treatments
Evolving Strategies in CIDP Care: Personalized Approaches and Emerging Treatments
Global Neurology Academy
Evolving Strategies in CIDP Care: Personalized Approaches and Emerging Treatments
Sami Khella, MD
- Sami Khella, MD
Genetics in Schizophrenia Management: Emerging Technological Strategies
Genetics in Schizophrenia Management: Emerging Technological Strategies
On the Frontlines of Schizophrenia
Genetics in Schizophrenia Management: Emerging Technological Strategies
Aaron Besterman, MD
- Aaron Besterman, MD
Understanding CIDP: A Roadmap to Diagnosis
Understanding CIDP: A Roadmap to Diagnosis
Global Neurology Academy
Understanding CIDP: A Roadmap to Diagnosis
Sami Khella, MD
- Sami Khella, MD

17/11